Philip Morris International Inc. (PM)

PM, MO and TPB are navigating declining cigarette sales and rising health awareness through smoke-free innovations and strategic portfolio expansion.

STAMFORD, CT--(BUSINESS WIRE)--Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration's (FDA) Center for Tobacco Products (CTP). The full-day meeting on October 7 was part of the FDA's customary review of PMI's request to continue marketing versions of its IQOS heated tobac.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

In the last decade, Philip Morris International (NYSE: PM) has returned a notable $74 billion back to its shareholders via dividends and buybacks. This shareholder-focused approach has delivered exceptional results in 2025, with the stock posting an impressive 30% year-to-date return, significantly outperforming the broader market despite recent volatility and establishing PM as one of the year's standout consumer staples performers.

By definition, blue chip stocks are the equities of companies long established in their businesses. Because these enterprises tend to be stable and generally profitable, many are also eager dividend payers who like to increase their distributions every year.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

Wilson facility expansion supports the business's mission to deliver a smoke-free future by providing legal-age adults who smoke with better alternatives  Reinforces PMI U.S.'s broader Invested in America platform to increase U.S. manufacturing and innovation capacity through strategic investment WILSON, N.C. , Oct. 2, 2025 /PRNewswire/ -- Philip Morris International's U.S. businesses (PMI U.S.) (NYSE: PM) today announced an investment of $37 million in their manufacturing facility in Wilson, North Carolina.

As we prepare for the fourth quarter of 2025, I find it very useful to look at the strongest stocks in 2025. I sort stocks on a year-to-date percent change basis.

Philip Morris delivered strong Q2 2024 results, driven by record revenues, robust smoke-free product growth, and expanding operating margins. Despite operational momentum, PM's current valuation appears stretched versus peers MO and BTI, making its risk/reward less attractive at current prices. Remain neutral on PM, expecting a retracement to around $147 before turning bullish again, which would offer a more compelling entry and a 4% dividend yield.

Philip Morris International (PM) remains a strong buy after a recent sell-off, with long-term growth prospects outweighing short-term concerns. PM's dominant positions in smokeless (Zyn) and heated tobacco (IQOS) markets, plus successful acquisitions, support robust earnings growth projections. Despite slower Zyn growth and regulatory headwinds, PM's innovation and market share gains in key segments reinforce its leadership and undervaluation.

Sequence of return risk can devastate retirement portfolios, especially when early negative returns coincide with withdrawals, undermining the traditional 4% rule. Dividend investing offers a powerful solution by providing steady cash flows that are largely independent of market volatility, neutralizing sequence risk. Building a portfolio of high-quality, dividend-growing stocks can deliver superior returns and reduce stress.

Seven of the top fifteen Barron's Better Bets (BBB) dividend 'dogs' - including CAG, PFE, VZ, BMY, UDR, KIM, and KEY - are attractively priced for income investors. Analyst forecasts project 17.61% to 34.78% net gains for top-ten BBB dogs by September 2026, with an average estimated gain of 23.96% and lower-than-market volatility. Five of the lowest-priced, highest-yield BBB stocks - CAG, PFE, VZ, BMY, and LYB - are expected to outperform higher-priced peers, offering a 16.89% advantage in projected returns.

There's a common idea that young investors should automatically gravitate to growth stocks and other riskier investments in the name of upside. Admittedly, young investors have a longer time horizon that affords them more time to endure volatility or recover from losses if an investment goes poorly.

Altria leans on pricing strength and nicotine pouch growth, while Philip Morris gains momentum with smoke-free products and global scale.

Building passive income is one of the most reliable ways to secure financial freedom. Instead of relying on active work for every paycheck, investors can put their money to work in dividend-paying stocks that send regular cash distributions straight to their brokerage accounts.

STAMFORD, Conn.--(BUSINESS WIRE)--A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes and growing worries about how public health decisions are made. The survey found that 78% of respondents agree that adult smokers in all countries should have access to better alternatives to continued smoking. Approximately three-quarters (74%) believe that encouraging people who.